Historique
Article de Périodique
Assessment and management of psychosis with coexisting substance misuse: summary of NICE guidance (Guidelines) (2011)
Auteur(s) :
KENDALL, T. ;
TYRER, P. ;
WHITTINGTON, C. ;
TAYLOR, C. ;
Guideline Development Group
Année
2011
Page(s) :
760-762 ; d1351
Langue(s) :
Anglais
Refs biblio. :
15
Domaine :
Plusieurs produits / Several products
Thésaurus mots-clés
TROUBLE BIPOLAIRE
;
RECOMMANDATION
;
PSYCHOSE
;
PRISE EN CHARGE
;
COMORBIDITE
;
FACTEUR DE RISQUE
;
ABUS
;
DEPENDANCE
Thésaurus géographique
ROYAUME-UNI
Résumé :
Many people with mental health problems use substances (including illicit drugs and alcohol), and for people with psychosis (predominantly schizophrenia and bipolar disorder), substance misuse occurs more frequently than in the general population. For example, a 1990 study in the United States reported a 47% lifetime prevalence rate of substance misuse among people with schizophrenia and 60% among people with bipolar disorder; in the general population, the substance misuse rate was 16%.
People with psychosis commonly take various non-prescribed substances to cope with their symptoms, and in about a third of people with psychosis, this amounts to hazardous, harmful, or dependent use. Among people with psychosis, those with coexisting substance misuse have a higher risk of relapse and admission to hospital, higher mortality, and higher levels of unmet needs. This is partly because the substances used may exacerbate the psychosis or interfere with pharmacological or psychological treatment.
This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on the assessment and management of psychosis and coexisting substance misuse in adults and young people.
People with psychosis commonly take various non-prescribed substances to cope with their symptoms, and in about a third of people with psychosis, this amounts to hazardous, harmful, or dependent use. Among people with psychosis, those with coexisting substance misuse have a higher risk of relapse and admission to hospital, higher mortality, and higher levels of unmet needs. This is partly because the substances used may exacerbate the psychosis or interfere with pharmacological or psychological treatment.
This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on the assessment and management of psychosis and coexisting substance misuse in adults and young people.
Affiliation :
1National Collaborating Centre for Mental Health, Royal College of Psychiatrists, London E1 8AA, United Kingdom / Royaume-Uni